Pfizer Wins Metsera: Obesity Drug Battle Concludes

Pfizer secures Metsera for over ten billion dollars, ending Novo Nordisks bid; Metseras board unanimously backs Pfizers offer due to superior value and certainty of closing; Novo Nordisk commits to financial discipline, seeking other acquisition opportunities.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.